Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
amantadine hydrochloride, Quantity: 100 mg
Novartis Pharmaceuticals Australia Pty Ltd
Capsule, soft
Excipient Ingredients: titanium dioxide; glycerol; lecithin; sodium propyl hydroxybenzoate; yellow beeswax; partially hydrogenated soya oil; iron oxide red; Gelatin; sodium ethyl hydroxybenzoate; hydrogenated soya oil; Rape Seed Oil; maize starch; sorbitol; mannitol; ethyl acetate; butan-1-ol; Shellac; industrial methylated spirit
Oral
100
Medicine Registered
(S4) Prescription Only Medicine
PARKINSON'S DISEASE: Idiopathic Parkinson's disease; post encephalitic parkinsonism; symptomatic parkinsonism (e.g. following CNS injury from carbon monoxide poisoning); arteriosclerotic parkinsonism; drug-induced extrapyramidal reactions. Symmetrel can be given alone for initial therapy or combined with anticholinergic drugs or L-dopa (see "Dosage and Administration"). Note: Symmetrel is not indicated for the treatment of tardive dyskinesia. TYPE A VIRUS INFLUENZA: Prophylaxis of respiratory tract illness caused by Influenza Type A. Prophylaxis in non-immunized individuals (including children) for whom influenza may have serious consequences (e.g. persons with chronic respiratory disease of diabetes mellitus).
Visual Identification: Reddish-brown, opaque, shiny, oblong capsule. One side branded "GEIGY", the other "GB", in white.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1991-08-02
SYMMETREL ® _amantadine hydrochloride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Symmetrel. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. Some more recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP TO DATE INFORMATION ON THE MEDICINE. YOU CAN ALSO DOWNLOAD THE MOST UP TO DATE LEAFLET FROM WWW.NOVARTIS.COM.AU. Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will provide. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT SYMMETREL IS USED FOR Symmetrel capsule has two very different uses: 1. to treat the symptoms of Parkinson's disease 2. to prevent a type of influenza ("the flu") caused by Type A influenza virus. PARKINSON'S DISEASE This is caused by a disturbance in the balance of two substances, dopamine and acetylcholine, that the brain uses to send signals to other parts of the body. Symmetrel helps to fix the imbalance of too little dopamine and/or too much acetylcholine; and to relieve the symptoms, such as shaking of the limbs, stiffness and slowness of movement which make it difficult to perform usual tasks. Symmetrel can be used alone or with other medicines to treat this condition. TYPE A INFLUENZA VIRUS Symmetrel is usually used for people who could become very ill if they get the flu infections (for example, people who have a serious illness such as lung disease or diabetes). Usually these people will have been vaccinated (had a flu shot). But if, for some reason, they have not been vaccinated, Symmetrel ca Read the complete document
1 AUSTRALIAN PRODUCT INFORMATION – SYMMETREL (AMANTADINE HYDROCHLORIDE) CAPSULES 1 NAME OF THE MEDICINE Amantadine hydrochloride. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains amantadine hydrochloride 100 mg. Excipients with known effect: contains hydroxybenzoates and sulfites. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM 100 mg capsules: brown, soft gelatin, marked "GEIGY" on one side and "GB" on reverse. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS PARKINSON'S DISEASE Idiopathic Parkinson's disease; post-encephalitic parkinsonism; symptomatic parkinsonism (e.g. following CNS injury from carbon monoxide poisoning); arteriosclerotic parkinsonism; drug-induced extrapyramidal reactions. Symmetrel can be given alone for initial therapy or combined with anticholinergic drugs or L-dopa (see section 4.2 Dose and method of administration). Note: Symmetrel is not indicated for the treatment of tardive dyskinesia. TYPE A VIRUS INFLUENZA Prophylaxis of respiratory tract illness caused by Influenza Type A. Prophylaxis in non-immunised individuals (including children) for whom influenza may have serious consequences (e.g. persons with chronic respiratory disease or diabetes mellitus). 4.2 D OSE AND METHOD OF ADMINISTRATION Before use in elderly patients or those with impaired liver or kidney function, refer to section 4.4 Special warnings and precautions for use and section 5.2 Pharmacokinetics properties. In patients over 65 years of age, both age and renal function should be taken into consideration. By age 65, renal function will typically have declined to a level at which reduced doses of Symmetrel or increased dosing interval are appropriate. Specific dosage schedules for patients over 65 years of age and those with impaired renal function are shown below. 2 RECOMMENDED DOSAGES PARKINSON’S DISEASE _Adults to 65 years _ When used alone, 100 mg daily for the first week of treatment, increasing in the second week to 100 mg twice daily. The dose can Read the complete document